Logo image of ALEO2.PA

EO2 (ALEO2.PA) Stock Fundamental Analysis

EPA:ALEO2 - Euronext Paris - Matif - FR0010465534 - Common Stock - Currency: EUR

2.68  -0.12 (-4.29%)

Fundamental Rating

2

Overall ALEO2 gets a fundamental rating of 2 out of 10. We evaluated ALEO2 against 59 industry peers in the Oil, Gas & Consumable Fuels industry. ALEO2 scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALEO2 has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ALEO2 was profitable.
ALEO2 had a negative operating cash flow in the past year.
In the past 5 years ALEO2 has always been profitable.
Of the past 5 years ALEO2 4 years had a positive operating cash flow.
ALEO2.PA Yearly Net Income VS EBIT VS OCF VS FCFALEO2.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M -6M

1.2 Ratios

ALEO2's Return On Assets of 1.60% is on the low side compared to the rest of the industry. ALEO2 is outperformed by 76.27% of its industry peers.
ALEO2 has a worse Return On Equity (3.48%) than 76.27% of its industry peers.
ALEO2 has a worse Return On Invested Capital (0.74%) than 79.66% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ALEO2 is significantly below the industry average of 15.03%.
Industry RankSector Rank
ROA 1.6%
ROE 3.48%
ROIC 0.74%
ROA(3y)4.32%
ROA(5y)3.34%
ROE(3y)9.77%
ROE(5y)7.71%
ROIC(3y)4.43%
ROIC(5y)3.25%
ALEO2.PA Yearly ROA, ROE, ROICALEO2.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

ALEO2 has a Profit Margin of 2.08%. This is in the lower half of the industry: ALEO2 underperforms 74.58% of its industry peers.
In the last couple of years the Profit Margin of ALEO2 has declined.
The Operating Margin of ALEO2 (1.19%) is worse than 77.97% of its industry peers.
In the last couple of years the Operating Margin of ALEO2 has declined.
ALEO2's Gross Margin of 42.46% is in line compared to the rest of the industry. ALEO2 outperforms 49.15% of its industry peers.
ALEO2's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.19%
PM (TTM) 2.08%
GM 42.46%
OM growth 3Y-4.51%
OM growth 5Y-16.63%
PM growth 3Y23.02%
PM growth 5Y-5.38%
GM growth 3Y25.04%
GM growth 5Y9.23%
ALEO2.PA Yearly Profit, Operating, Gross MarginsALEO2.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALEO2 is destroying value.
The number of shares outstanding for ALEO2 has been reduced compared to 1 year ago.
The number of shares outstanding for ALEO2 has been reduced compared to 5 years ago.
ALEO2 has a worse debt/assets ratio than last year.
ALEO2.PA Yearly Shares OutstandingALEO2.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
ALEO2.PA Yearly Total Debt VS Total AssetsALEO2.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

ALEO2 has an Altman-Z score of 1.74. This is a bad value and indicates that ALEO2 is not financially healthy and even has some risk of bankruptcy.
ALEO2's Altman-Z score of 1.74 is in line compared to the rest of the industry. ALEO2 outperforms 44.07% of its industry peers.
ALEO2 has a Debt/Equity ratio of 0.50. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.50, ALEO2 is in line with its industry, outperforming 47.46% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF N/A
Altman-Z 1.74
ROIC/WACC0.11
WACC6.49%
ALEO2.PA Yearly LT Debt VS Equity VS FCFALEO2.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M 20M

2.3 Liquidity

ALEO2 has a Current Ratio of 2.59. This indicates that ALEO2 is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.59, ALEO2 is in the better half of the industry, outperforming 79.66% of the companies in the same industry.
A Quick Ratio of 1.80 indicates that ALEO2 should not have too much problems paying its short term obligations.
ALEO2 has a Quick ratio of 1.80. This is in the better half of the industry: ALEO2 outperforms 69.49% of its industry peers.
Industry RankSector Rank
Current Ratio 2.59
Quick Ratio 1.8
ALEO2.PA Yearly Current Assets VS Current LiabilitesALEO2.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

1

3. Growth

3.1 Past

The earnings per share for ALEO2 have decreased strongly by -96.09% in the last year.
The Earnings Per Share has been growing slightly by 0.52% on average over the past years.
ALEO2 shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -31.55%.
The Revenue has been growing slightly by 5.99% on average over the past years.
EPS 1Y (TTM)-96.09%
EPS 3Y35.45%
EPS 5Y0.52%
EPS Q2Q%-58.53%
Revenue 1Y (TTM)-31.55%
Revenue growth 3Y11.24%
Revenue growth 5Y5.99%
Sales Q2Q%-17.61%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALEO2.PA Yearly Revenue VS EstimatesALEO2.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ALEO2.PA Yearly EPS VS EstimatesALEO2.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 0.1 0.2 0.3 0.4 0.5

0

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 38.29 indicates a quite expensive valuation of ALEO2.
ALEO2's Price/Earnings ratio is a bit more expensive when compared to the industry. ALEO2 is more expensive than 74.58% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.30. ALEO2 is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 38.29
Fwd PE N/A
ALEO2.PA Price Earnings VS Forward Price EarningsALEO2.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ALEO2.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.44
ALEO2.PA Per share dataALEO2.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)72.98
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ALEO2!.
Industry RankSector Rank
Dividend Yield N/A

EO2

EPA:ALEO2 (7/11/2025, 7:00:00 PM)

2.68

-0.12 (-4.29%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners28.33%
Ins Owner ChangeN/A
Market Cap6.43M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 38.29
Fwd PE N/A
P/S 0.19
P/FCF N/A
P/OCF N/A
P/B 0.32
P/tB 0.34
EV/EBITDA 5.44
EPS(TTM)0.07
EY2.61%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-2.82
FCFYN/A
OCF(TTM)-1.1
OCFYN/A
SpS14.2
BVpS8.5
TBVpS7.82
PEG (NY)N/A
PEG (5Y)72.98
Profitability
Industry RankSector Rank
ROA 1.6%
ROE 3.48%
ROCE 1.14%
ROIC 0.74%
ROICexc 0.93%
ROICexgc 0.98%
OM 1.19%
PM (TTM) 2.08%
GM 42.46%
FCFM N/A
ROA(3y)4.32%
ROA(5y)3.34%
ROE(3y)9.77%
ROE(5y)7.71%
ROIC(3y)4.43%
ROIC(5y)3.25%
ROICexc(3y)7.15%
ROICexc(5y)5.22%
ROICexgc(3y)7.62%
ROICexgc(5y)5.52%
ROCE(3y)6.78%
ROCE(5y)4.98%
ROICexcg growth 3Y-0.06%
ROICexcg growth 5Y-15.64%
ROICexc growth 3Y-0.72%
ROICexc growth 5Y-16.61%
OM growth 3Y-4.51%
OM growth 5Y-16.63%
PM growth 3Y23.02%
PM growth 5Y-5.38%
GM growth 3Y25.04%
GM growth 5Y9.23%
F-Score3
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF N/A
Debt/EBITDA 4.41
Cap/Depr 218.47%
Cap/Sales 12.12%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.59
Quick Ratio 1.8
Altman-Z 1.74
F-Score3
WACC6.49%
ROIC/WACC0.11
Cap/Depr(3y)123.02%
Cap/Depr(5y)99.34%
Cap/Sales(3y)7.35%
Cap/Sales(5y)6.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-96.09%
EPS 3Y35.45%
EPS 5Y0.52%
EPS Q2Q%-58.53%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-31.55%
Revenue growth 3Y11.24%
Revenue growth 5Y5.99%
Sales Q2Q%-17.61%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-93.7%
EBIT growth 3Y6.23%
EBIT growth 5Y-11.64%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-264.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-147.88%
OCF growth 3YN/A
OCF growth 5YN/A